The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC)
European Respiratory Journal · 2025-10 · 66 (4) · 2500287
DOI: 10.1183/13993003.00287-2025 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Respiratory Journal, online erschienen am 21.08.2025. Verfasst von Hollian Richardson und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Microbiota, Adrenal Cortex Hormones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: AstraZeneca.
Themen: COPD
Abstract (Originalsprache)
Background
The microbiome is associated with exacerbation risk, quality of life and mortality in COPD. Inhaled corticosteroid (ICS) treatment has been reported to alter the microbiome through modulating host defence. How ICS alters the microbiome and whether effects are equal between different ICS preparations is debated. The aim of the MUSIC trial was to investigate whether commonly used ICS therapies have different effects on the airway microbiome in COPD.
Methods
This was a multicentre randomised controlled trial. After a 4-week washout period during which they withdrew from ICS, patients with COPD (forced expiratory volume in 1 s
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK.
- Division of Population Health and Genomics, University of Dundee, Dundee, UK.
- Tayside Clinical Trials Unit, Dundee, UK.
- Department of Respiratory Medicine, Wishaw General Hospital, NHS Lanarkshire, Wishaw, UK.
- Department of Respiratory Medicine, Blackpool Victoria Hospital, Blackpool, UK.
- University of Edinburgh, Respiratory and Environmental Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
ORCID-Profile: Daniela Alferes De Lima Headley, Petra Rauchhaus, Holly R Keir, Gourab Choudhury
Förderung
- AstraZeneca
Zitieren
APA
Richardson, H., Alferes De Lima Headley, D., Clarke, C., Veluchamy, A., Rauchhaus, P., Pollock, J., Pembridge, T., Cassidy, D., Keir, H. R., Finch, S., Hussain, F., Band, M., Smith, A., Patel, M., Paracha, M., Choudhury, G., Dhasmana, D., Chaudhuri, R., Short, P. M., & Chalmers, J. D. (2025). The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC). European Respiratory Journal, 66(4), 2500287. https://doi.org/10.1183/13993003.00287-2025
Vancouver
Richardson H, Alferes De Lima Headley D, Clarke C, Veluchamy A, Rauchhaus P, Pollock J, et al. The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC). European Respiratory Journal. 2025;66(4):2500287. doi:10.1183/13993003.00287-2025
BibTeX
@article{Richardson2025,
author = {Richardson, Hollian and Alferes De Lima Headley, Daniela and Clarke, Clare and Veluchamy, Abirami and Rauchhaus, Petra and Pollock, Jennifer and Pembridge, Thomas and Cassidy, Diane and Keir, Holly R and Finch, Simon and Hussain, Furrah and Band, Margaret and Smith, Andrew and Patel, Manish and Paracha, Mohammad and Choudhury, Gourab and Dhasmana, Devesh and Chaudhuri, Rekha and Short, Philip M and Chalmers, James D},
title = {The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe COPD: a randomised trial (MUSIC)},
journal = {European Respiratory Journal},
year = {2025},
volume = {66},
number = {4},
pages = {2500287},
doi = {10.1183/13993003.00287-2025}
}
EUVIMED